Cargando…
The efficacy of dexamethasone on reduction in the reoperation rate of chronic subdural hematoma – the DRESH study: straightforward study protocol for a randomized controlled trial
BACKGROUND: Chronic subdural hematoma (cSDH) is a common neurosurgical disease. It is often considered to be a rather benign entity. In spite of well established surgical procedures cSDH is complicated by a recurrence rate up to 30%. Since glucocorticoids have been used for treatment of cSDH in 1962...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891985/ https://www.ncbi.nlm.nih.gov/pubmed/24393328 http://dx.doi.org/10.1186/1745-6215-15-6 |
_version_ | 1782299438978433024 |
---|---|
author | Emich, Stephan Richling, Bernd McCoy, Marc R Al-Schameri, Rahman Abdul Ling, Feng Sun, Liyong Wang, Yabing Hitzl, Wolfgang |
author_facet | Emich, Stephan Richling, Bernd McCoy, Marc R Al-Schameri, Rahman Abdul Ling, Feng Sun, Liyong Wang, Yabing Hitzl, Wolfgang |
author_sort | Emich, Stephan |
collection | PubMed |
description | BACKGROUND: Chronic subdural hematoma (cSDH) is a common neurosurgical disease. It is often considered to be a rather benign entity. In spite of well established surgical procedures cSDH is complicated by a recurrence rate up to 30%. Since glucocorticoids have been used for treatment of cSDH in 1962 their role is still discussed controversially in lack of evident data. On the basis of the ascertained inflammation cycle in cSDH dexamethasone will be an ideal substance for a short lasting, concomitant treatment protocol. Objective: to test the efficacy of dexamethasone on reduction inthe reoperation rate of cSDH. METHODS/DESIGN: The study is designed as a double-blind randomized placebo-controlled trial 820 patients who are operated for cSDH and from the age of 25 years are included after obtaining informed consent. They are randomized for administration of dexamethasone (16-16-12-12-8-4 mg/d) or placebo (maltodextrin) during the first 48 hours after surgery. The type I error is 5% and the type II error is 20%. The primary endpoint is the reoperation within 12 weeks postoperative. DISCUSSION: This study tests whether dexamethasone administered over 6 days is a safe and potent agent in relapse prevention for evacuated cSDH. TRIAL REGISTRATION: EudraCT 201100354442 |
format | Online Article Text |
id | pubmed-3891985 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-38919852014-01-15 The efficacy of dexamethasone on reduction in the reoperation rate of chronic subdural hematoma – the DRESH study: straightforward study protocol for a randomized controlled trial Emich, Stephan Richling, Bernd McCoy, Marc R Al-Schameri, Rahman Abdul Ling, Feng Sun, Liyong Wang, Yabing Hitzl, Wolfgang Trials Study Protocol BACKGROUND: Chronic subdural hematoma (cSDH) is a common neurosurgical disease. It is often considered to be a rather benign entity. In spite of well established surgical procedures cSDH is complicated by a recurrence rate up to 30%. Since glucocorticoids have been used for treatment of cSDH in 1962 their role is still discussed controversially in lack of evident data. On the basis of the ascertained inflammation cycle in cSDH dexamethasone will be an ideal substance for a short lasting, concomitant treatment protocol. Objective: to test the efficacy of dexamethasone on reduction inthe reoperation rate of cSDH. METHODS/DESIGN: The study is designed as a double-blind randomized placebo-controlled trial 820 patients who are operated for cSDH and from the age of 25 years are included after obtaining informed consent. They are randomized for administration of dexamethasone (16-16-12-12-8-4 mg/d) or placebo (maltodextrin) during the first 48 hours after surgery. The type I error is 5% and the type II error is 20%. The primary endpoint is the reoperation within 12 weeks postoperative. DISCUSSION: This study tests whether dexamethasone administered over 6 days is a safe and potent agent in relapse prevention for evacuated cSDH. TRIAL REGISTRATION: EudraCT 201100354442 BioMed Central 2014-01-06 /pmc/articles/PMC3891985/ /pubmed/24393328 http://dx.doi.org/10.1186/1745-6215-15-6 Text en Copyright © 2014 Emich et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Study Protocol Emich, Stephan Richling, Bernd McCoy, Marc R Al-Schameri, Rahman Abdul Ling, Feng Sun, Liyong Wang, Yabing Hitzl, Wolfgang The efficacy of dexamethasone on reduction in the reoperation rate of chronic subdural hematoma – the DRESH study: straightforward study protocol for a randomized controlled trial |
title | The efficacy of dexamethasone on reduction in the reoperation rate of chronic subdural hematoma – the DRESH study: straightforward study protocol for a randomized controlled trial |
title_full | The efficacy of dexamethasone on reduction in the reoperation rate of chronic subdural hematoma – the DRESH study: straightforward study protocol for a randomized controlled trial |
title_fullStr | The efficacy of dexamethasone on reduction in the reoperation rate of chronic subdural hematoma – the DRESH study: straightforward study protocol for a randomized controlled trial |
title_full_unstemmed | The efficacy of dexamethasone on reduction in the reoperation rate of chronic subdural hematoma – the DRESH study: straightforward study protocol for a randomized controlled trial |
title_short | The efficacy of dexamethasone on reduction in the reoperation rate of chronic subdural hematoma – the DRESH study: straightforward study protocol for a randomized controlled trial |
title_sort | efficacy of dexamethasone on reduction in the reoperation rate of chronic subdural hematoma – the dresh study: straightforward study protocol for a randomized controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891985/ https://www.ncbi.nlm.nih.gov/pubmed/24393328 http://dx.doi.org/10.1186/1745-6215-15-6 |
work_keys_str_mv | AT emichstephan theefficacyofdexamethasoneonreductioninthereoperationrateofchronicsubduralhematomathedreshstudystraightforwardstudyprotocolforarandomizedcontrolledtrial AT richlingbernd theefficacyofdexamethasoneonreductioninthereoperationrateofchronicsubduralhematomathedreshstudystraightforwardstudyprotocolforarandomizedcontrolledtrial AT mccoymarcr theefficacyofdexamethasoneonreductioninthereoperationrateofchronicsubduralhematomathedreshstudystraightforwardstudyprotocolforarandomizedcontrolledtrial AT alschamerirahmanabdul theefficacyofdexamethasoneonreductioninthereoperationrateofchronicsubduralhematomathedreshstudystraightforwardstudyprotocolforarandomizedcontrolledtrial AT lingfeng theefficacyofdexamethasoneonreductioninthereoperationrateofchronicsubduralhematomathedreshstudystraightforwardstudyprotocolforarandomizedcontrolledtrial AT sunliyong theefficacyofdexamethasoneonreductioninthereoperationrateofchronicsubduralhematomathedreshstudystraightforwardstudyprotocolforarandomizedcontrolledtrial AT wangyabing theefficacyofdexamethasoneonreductioninthereoperationrateofchronicsubduralhematomathedreshstudystraightforwardstudyprotocolforarandomizedcontrolledtrial AT hitzlwolfgang theefficacyofdexamethasoneonreductioninthereoperationrateofchronicsubduralhematomathedreshstudystraightforwardstudyprotocolforarandomizedcontrolledtrial AT emichstephan efficacyofdexamethasoneonreductioninthereoperationrateofchronicsubduralhematomathedreshstudystraightforwardstudyprotocolforarandomizedcontrolledtrial AT richlingbernd efficacyofdexamethasoneonreductioninthereoperationrateofchronicsubduralhematomathedreshstudystraightforwardstudyprotocolforarandomizedcontrolledtrial AT mccoymarcr efficacyofdexamethasoneonreductioninthereoperationrateofchronicsubduralhematomathedreshstudystraightforwardstudyprotocolforarandomizedcontrolledtrial AT alschamerirahmanabdul efficacyofdexamethasoneonreductioninthereoperationrateofchronicsubduralhematomathedreshstudystraightforwardstudyprotocolforarandomizedcontrolledtrial AT lingfeng efficacyofdexamethasoneonreductioninthereoperationrateofchronicsubduralhematomathedreshstudystraightforwardstudyprotocolforarandomizedcontrolledtrial AT sunliyong efficacyofdexamethasoneonreductioninthereoperationrateofchronicsubduralhematomathedreshstudystraightforwardstudyprotocolforarandomizedcontrolledtrial AT wangyabing efficacyofdexamethasoneonreductioninthereoperationrateofchronicsubduralhematomathedreshstudystraightforwardstudyprotocolforarandomizedcontrolledtrial AT hitzlwolfgang efficacyofdexamethasoneonreductioninthereoperationrateofchronicsubduralhematomathedreshstudystraightforwardstudyprotocolforarandomizedcontrolledtrial |